Objectives-To investigate the involvement of the adhesion molecule CD44 in the homing of lymphocytes to synovial tissue, by examining the density of expression and molecular mass of CD44 on rheumatoid synovial fluid lymphocytes. Methods-Twenty patients with rheumatoid arthritis were studied. Peripheral blood and synovial fluid lymphocytes were isolated by Ficoll-Hypaque sedimentation. CD44 expression was analysed by two colour flow cytometry of CD3 positive T lymphocytes with calculation of mean fluorescence intensity. Expression of activation markers M21C5, M2B3, interleukin (IL)-2 receptor and transferrin receptor was quantitated. In addition, CD44 molecular mass was examined by Western blot in six patients. Results-CD44 expression was markedly increased on synovial fluid T lymphocytes of rheumatoid patients relative to peripheral blood lymphocytes from the same individuals. CD44 molecular mass on peripheral blood mononuclear cells was 88 kDa, but that on synovial fluid lymphocytes was only 83 kDa. CD44 expression correlated significantly with expression of activation markers M21C5, M2B3, and the IL-2 receptor.
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(Ann Rheum Dis 1995; 54: 566-570) Several cell surface receptors have been identified as homing receptors for human T cells; these molecules direct the lymphocyte to putative tissue targets.' 2 Antibodies directed against such homing receptors block migration of lymphocytes in a tissue selective fashion in vivo, and also block binding of lymphocytes to high endothelial venules in the target tissue in vitro.3 4 Receptors identified as important in migration of lymphocytes to the synovium in mouse models include the molecules lymphocyte function associated antigen (LFA)-1 (CD I 1 a/CD 18)1 and phosphoglycoprotein (Pgp)-1 (CD44).5 These molecules may both be blocked by inhibitory antibodies which prevent migration of T cells to the inflamed synovium.
CD44 is a molecule which has been found to be expressed on a wide variety of cells and which possesses differing molecular mass isoforms.6 It was first identified as a homing receptor involved in migration to the mouse regional lymphoid organs. More recently, it has been identified as a receptor for hyaluronic acid, although it appears that this molecule may have multiple ligands.7 The multiple isoforms expressed by CD44 have been recognised not only on the basis of differential glycosylation, but also by means of alternate splicing of a range of different exons;5 expression of alternatively spliced variant forms of the molecule is associated with migration and metastasis of tumour cells.9 In a previous study it has been reported that CD44 expression is increased on rheumatoid synovial fluid lymphocytes; however, the nature of the cells expressing increased CD44 was not characterised.
"
In this study, we have examined the expression of CD44 in synovial fluid CD3 positive T lymphocytes derived from rheumatoid arthritis (RA) synovial fluid and in T lymphocytes derived from peripheral blood of patients with RA. In addition, we have examined the expression of LFA-1 and the activation markers interleukin (IL)-2 receptor, transferrin receptor, and the more recently described monoclonal markers, M2 1 C5l and M2B3'2 on these lymphocytes.
Patients and methods

PATIENTS
Twenty patients with RA were studied. Peripheral blood and synovial fluid were obtained contemporaneously from RA patients. Mononuclear cells were isolated from blood and synovial fluid by Ficoll-Hypaque sedimentation. Cell yields from synovial fluid ranged from 1 2 X 106/ml to 6 5 X 106/ml (median 2-4 x 106/ml). Lymphocytes from normal individuals were cultivated for three days in vitro in RPMI 1640 medium (Gibco, Life Technologies Ltd, Paisley, Scotland) containing 100 U/ml penicillin, 100 ,ug/ml streptomycin, 20 mmol/l L-glutamine and 10% fetal calf serum in the presence of the T cell mitogen, phytohaemagglutinin (PHA). After culture, lymphocytes were removed and immunofluorescence staining performed as previously described for LFA-1 and CD44. IMMUNOBLOT 
ANALYSIS
Peripheral blood T cells and synovial fluid T cells were washed in PBS, pH 7-2, centrifuged at 250 g for five minutes and resuspended in 1 ml of buffer containing 1% Triton-X-100, 0 5 mmol/l EGTA, 0 1 mmol/l phenyl methylsulphonyl fluoride, and leupeptin 10 ,ug/ml. This lysate was gently agitated at 4°C for 30 minutes and centrifuged at 200 g for 10 minutes. The resultant supernatant was then spun at 100 000 g for 30 minutes at 4°C using a Beckman L5-50 ultracentrifuge equipped with a SW 41 rotor. Proteins were separated by polyacrylamide gel electrophoresis (10%) and electrophoretically transferred to a nitrocellulose membrane. The membrane was blocked using Blotto Tween solution (5% nonfat dried milk/0-05% Tween 20) in PBS at pH 7-2 and then incubated with monoclonal antibody to CD44, Bric 238, and control monoclonal antibody, anti-vimentin, in PBS/ Blotto Tween for 18 hours, followed by biotinylated sheep anti-mouse antibody (one hour) and streptavidin-biotinylated horseradish peroxidase complex in 1% gelatin for 30 minutes. Immunoreactive bands were visualised by treatment with 3-amino-9-ethylcarbimazole. Molecular (fig 2) . Table 1 compares the distribution of the biphasic and uniphasic populations of LFA-1 expressing cells between peripheral blood and synovial fluid lymphocytes in RA patients, and shows that the proportions of each population in peripheral blood reflected those found in normal individuals.
In agreement with a previous report, the percentage of CD4 and CD8 positive cells did not differ significantly from that seen in peripheral blood.'3 Furthermore, neither Cultivation of lymphocytes for three days increased expression of CD44; activation with PHA did not significantly augment this increase (table 2) . However, three day cultivation of lymphocytes with PHA significantly increased the level of LFA-1 expression and converted the biphasic peak to a uniphasic peak (in preparation-data not shown). No of cells expressing LFA-1 This reduction is consistent with deglycosylation, or possibly dephosphorylation, and could potentially change ligand binding/ homing properties of the molecule. In this regard it is notable that the LFA-1 molecule becomes activated on dephosphorylation, with resultant increases in homotypic aggregation. 24 The CD44 molecule is also a signalling molecule with potential for signalling production of cytokines including TNF,25 and for signalling upregulation of other adhesion molecules such as LFA-1.26 Upregulation of LFA-1 may potentiate T cell activation27 and may also facilitate either generation of cytoskeletal changes associated with a locomotion associated phenotype28 or, alternatively, homotypic aggregation.29 Thus interaction with putative ligands within the rheumatoid synovium may result in the amplification of the local inflammatory response. In addition, increased soluble CD44 has been demonstrated in synovial fluid, possibly related to release from the synovial membrane, and this, in addition to increased tissue CD44, could potentially have a consumptive effect on synovial fluid hyaluronic acid, with resultant decrease in synovial fluid viscosity.30 Thus this molecule might contribute to joint damage in rheumatoid patients in a number of ways, either directly or indirectly through effects on other adhesion molecules. Soluble hyaluronate has been reported to depress T cell proliferative responses, possibly by binding to CD44;31 soluble CD44 complexed to liposomes also depressed T cell proliferative responses. 30 Hence, it cannot be assumed that the increased CD44 is associated with functional activation of synovial fluid lymphocytes. Further studies are required to determine the mechanisms involved in the reduction of molecular mass of CD44 in RA synovial fluid. In particular, the development of monoclonal antibodies to peptides specific to individual CD44 exons should facilitate assessment of exon utilisation in this condition. 
